Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $220
Benzinga Newsdesk 9 months ago
NewsPrice TargetAnalyst Ratings
Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Line and raises the price target from $190 to $220.
Evercore ISI Group analyst Elizabeth Anderson maintains Quest Diagnostics (NYSE:DGX) with a In-Line and raises the price target from $190 to $220.